Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling

Código QR

Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling

Abstract TGFβ signaling plays crucial role during development and cancer, however the role for TGFβ signaling in regulating the noncoding part of the human genome in triple negative breast cancer (TNBC) is still being unraveled. Herein, we provide the transcriptional landscape of TNBC in response to...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Radhakrishnan Vishnubalaji, Nehad M. Alajez
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/70b0fdd9d04744d38c5c5b3d07a3f568
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer
por: Hibah Shaath, et al.
Publicado: (2021)

Convergence of TGFβ and BMP signaling in regulating human bone marrow stromal cell differentiation
por: Mona Elsafadi, et al.
Publicado: (2019)

Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
por: Manvi Sharma, et al.
Publicado: (2021)

EGR1 and RXRA transcription factors link TGF-β pathway and CCL2 expression in triple negative breast cancer cells
por: Alisa M. Gorbacheva, et al.
Publicado: (2021)

Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer
por: Joseph T. Decker, et al.
Publicado: (2021)

Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
por: Tiffany Scully, et al.
Publicado: (2021)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis
por: Xiaolong Tang, et al.
Publicado: (2017)

TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy
por: Ariella Zehender, et al.
Publicado: (2021)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

TGF-β Signaling and Resistance to Cancer Therapy
por: Maoduo Zhang, et al.
Publicado: (2021)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner J, et al.
Publicado: (2015)

Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
por: Chiara Giacomelli, et al.
Publicado: (2021)

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
por: Wen-Hung Kuo, et al.
Publicado: (2012)

BRCA2 mutations and triple-negative breast cancer.
por: Peter Meyer, et al.
Publicado: (2012)

Triple-negative breast cancer: treatment challenges and solutions
por: Collignon J, et al.
Publicado: (2016)

Opportunities for metastatic triple negative breast cancer therapy
por: Inna P. Ganshina, et al.
Publicado: (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype
por: Inna P. Ganshina, et al.
Publicado: (2021)

LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women
por: Torres-Luquis O, et al.
Publicado: (2018)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
por: Marina K. Ibragimova, et al.
Publicado: (2021)

MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
por: Dawid Mehlich, et al.
Publicado: (2021)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman ML, et al.
Publicado: (2015)

Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer
por: Xin Zheng, et al.
Publicado: (2021)

Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.
por: Rajeshwari Mehta, et al.
Publicado: (2013)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Paolo Peterlongo, et al.
Publicado: (2021)

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
por: L. E. Anselmino, et al.
Publicado: (2021)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Gábor Cserni, et al.
Publicado: (2021)

TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
por: Oihana Iriondo, et al.
Publicado: (2018)

A new immunochemical strategy for triple-negative breast cancer therapy
por: Chih-Wei Lin, et al.
Publicado: (2021)

Peptide density targets and impedes triple negative breast cancer metastasis
por: Daxing Liu, et al.
Publicado: (2018)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher B, et al.
Publicado: (2016)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
por: Inna P. Ganshina, et al.
Publicado: (2021)

Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
por: Alberto Aranza-Martínez, et al.
Publicado: (2021)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Anna E. M. Bastiaansen, et al.
Publicado: (2020)

Co-dependency for MET and FGFR1 in basal triple-negative breast cancers
por: Vanessa Y. C. Sung, et al.
Publicado: (2021)

Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.
por: Katsuhiro Yoshikawa, et al.
Publicado: (2021)

Expression of LGR5 in mammary myoepithelial cells and in triple-negative breast cancers
por: Hyun Ju Lee, et al.
Publicado: (2021)

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
por: Corey Speers, et al.
Publicado: (2017)

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
por: da Silva JL, et al.
Publicado: (2021)

Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
por: Bowen Gao, et al.
Publicado: (2021)